Bay Street News, 2024

WARRINGTON, Pa., Feb. 01, 2024 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company […]

New contract adds to Evtec’s existing order book of $780 million Parts supplied by Evtec to be used in new […]

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma […]

CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop universal-RAS/RAF […]

CALGARY, Alberta, Feb. 01, 2024 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra” or the “Company”) (NYSE American:GTE) (TSX:GTE) (LSE:GTE) today […]

MONTREAL, Feb. 01, 2024 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC – “Earth Alive” or the “Company”), […]

NOVI, Mich., Feb. 01, 2024 (GLOBE NEWSWIRE) — The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North […]

Sales increased 3% to $4.8 billion; organic sales increased 3% Segment operating margin was 21.1%, or a record 24.5% adjusted, […]

WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on […]

TROY, Mich., Feb. 01, 2024 (GLOBE NEWSWIRE) — Kelly, a leading global specialty talent solutions provider, will release its fourth-quarter […]